Telomerase insufficiency in rheumatoid arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 11, 2009, Pages 4360-4365

  Fujii, Hiroshi ^a   Shao, Lan ^a   Colmegna, Inés ^a   Goronzy, Jörg J ^a   Yand, Cornelia M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autoimmunity; Immunosenescence; Pathogenesis; Telomere

Indexed keywords

CD34 ANTIGEN; T LYMPHOCYTE RECEPTOR; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL CYCLE PROGRESSION; CELL EXPANSION; CELL LOSS; CELL STIMULATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME INDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTOPENIA; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELL AGING; DOWN-REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; TELOMERASE; TELOMERE;

EID: 63149145433     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0811332106     Document Type: Article

References (44)

1. Skapenko A, Lipsky PE, Schulze-Koops H (2006) T cell activation as starter and motor of rheumatic inflammation. Curr Top Microbiol Immunol 305:195-211.
2. Weyand CM, Goronzy JJ (2006) T-cell-targeted therapies in rheumatoid arthritis. Nat Clin Pract Rheumatol 2:201-210.
3. Weyand CM, Kurtin PJ,GoronzyJJ (2001) Ectopic lymphoid organogenesis: A fasttrack for autoimmunity. Am J Pathol 159:787-793.
4. Goronzy JJ, Weyand CM (2003) Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity-catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 5:225-234.
5. Koetz K, et al. (2000) T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 97:9203-9208.
6. Schonland SO, et al. (2003) Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 100:13471-13476.
7. Salmon M, Akbar AN (2004) Telomere erosion: A new link between HLA DR4 and rheumatoid arthritis? Trends Immunol 25:339-341.
8. Akbar AN, Beverley PC, Salmon M (2004) Will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol 4:737-743.
9. Reed JR, et al. (2004) Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo. J Exp Med 199:1433-1443.
10. Soares MV, et al. (2004) Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection. Blood 103:162-167.
11. Fritsch RD, et al. (2005) Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 175:6489-6497.
12. Plunkett FJ, et al. (2007) The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol 178:7710-7719.
13. Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol Rev88:557-579.
14. McEachern MJ, Krauskopf A, Blackburn EH (2000) Telomeres and their control. Annu Rev Genet 34:331-358.
15. Weng NP, Levine BL, June CH, Hodes RJ (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183:2471-2479.
16. Hodes RJ, Hathcock KS, Weng NP (2002) Telomeres in T and B cells. Nat Rev Immunol 2:699-706.
17. Luiten RM, Pene J, Yssel H, Spits H (2003) Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis. Blood 101:4512-4519.
18. Roth A, et al. (2003) Telomerase levels control the lifespan of human T lymphocytes. Blood 102:849-857.
19. Roth A, et al. (2005) Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT. Blood 106:43-50.
20. Rufer N, et al. (2001) Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential. Blood 98:597-603.
21. VulliamyT, Dokal I(2006) Dyskeratosis congenita. Semin Hematol 43:157-166.
22. VulliamyT, et al. (2001) The RNA componentof telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413:432-435.
23. Armanios M, et al. (2005) Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA 102:15960-15964.
24. Marrone A, et al. (2007) Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood 110:4198-4205.
25. Knudson M, Kulkarni S, Ballas ZK, Bessler M, Goldman F (2005) Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis con-genita. Blood 105:682-688.
26. Fudenberg HH, Goust JM, Vesole DH, Salinas CF (1979) Active and suppressor T cells: diminution in a patient with dyskeratosis congenita and in first-degree relatives. Gerontology 25:231-237.
27. Colmegna I, et al. (2008) Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 58:990-1000.
28. Bodnar AG, Kim NW, Effros RB, Chiu CP (1996) Mechanism of telomerase induction during T cell activation. Exp Cell Res 228:58-64
29. 29.Bodnar AG, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
30. Stewart SA, Weinberg RA (2006) Telomeres: Cancer to human aging. Annu Rev Cell Dev Biol 22:531-557.
31. Beliveau A, et al. (2007) p53-dependent integration of telomere and growth factor deprivation signals. Proc Natl Acad Sci USA 104:4431-4436.
32. Slijepcevic P (2006) The role of DNA damage response proteins at telomeres-an "integrative" model. DNA Repair (Amst) 5:1299-1306.
33. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858-5868.
34. Hao LY, Strong MA, Greider CW (2004) Phosphorylation of H2AX at short telomeres in Tcells and fibroblasts. J Biol Chem 279:45148-45154.
35. de Lange T (2005) Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev 19:2100-2110.
36. Blackburn EH (2001) Switching and signaling at the telomere. Cell 106:661-673.
37. Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ (1998) Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. J Immunol 161:1018-1025.
38. Pryshchep S, Sato K, Goronzy JJ, Weyand CM (2006) T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res 98:1168-1176.
39. Sato K, et al. (2006) TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med 203:239-250.
40. Giles JT, Post W, Blumenthal RS, Bathon JM (2006) Therapy Insight: Managing cardiovascular risk in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 2:320-329.
41. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study. Arthritis Rheum 46:2287-2293.
42. Quah BJ, Warren HS, Parish CR (2007) Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2:2049-2056.
43. Wege H, Chui MS, Le HT, Tran JM, Zern MA (2003) SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res 31:e3.
44. Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30:e47.